Chris Rose
Chris Rose@ArchRose90
A Black Lives Matters protest in London regarding Chris Kaba. Looks like the white, middle class organisers forget to invite any black people.
Tommy Robinson
Tommy Robinson@TRobinsonNewEra
In the wake of death of UK political prisoner, Peter Lynch, who was fast tracked into prison for essentially shouting in the street. The grandfather was ultimately sentenced to death. Pakistani family who attacked police at Manchester Airport, STILL haven't even been charged.
Turning Point UK
Turning Point UK@TPointUK
Tiny ‘Black Lives Matter’ crowd gathers outside the Old Bailey courtrooms to protest the not guilty verdict of the police officer who shot violent criminal Chris Kaba. Kaba rammed his car repeatedly into armed police officers’ cars. BLM is finished in the UK.

Get you up to speed: Californians voice concerns ahead of elections: "Crime on every level"

Voters in California will head to the polls next week to select new leaders. The mayoral race in Los Angeles is particularly competitive, with crime being a significant issue.

Voting in California is scheduled for next week, with significant attention on the mayoral race in Los Angeles amidst rising crime concerns. The outcome could shape local policies, particularly in addressing crime and public safety in the city.

Officials in California are closely monitoring the mayoral race in Los Angeles, particularly regarding its implications for crime policy. Voters will decide on new leadership next week, which could lead to significant changes in local governance and public safety measures.

What remains unclear — It is not specified how the candidates’ crime policies differ or their potential impact on the election outcome.

Californians express concerns about crime ahead of upcoming elections

In California, voters across the state head to the polls next week to choose new leaders. In Los Angeles, the race for mayor is hotly contested, and so is the issue of crime. Adam Yamaguchi is there with more.

Get you up to speed: The London couple at the heart of ‘first-of-its-kind’ Alzheimer’s treatment | News UK

Denis Horton, 75, and his wife Penny, 74, have been involved in a pioneering clinical trial for early onset Alzheimer’s at University College Hospital in London. Following her diagnosis, the couple is participating in research to treat brain inflammation associated with the disease.

Penny Horton is participating in a pioneering clinical study at University College Hospital, aimed at exploring treatments for Alzheimer’s through addressing brain inflammation. Researchers, led by Professor Catherine Mummery, report promising early findings, indicating no adverse side effects and potential improvements in the condition.

University College Hospital’s Professor Catherine Mummery emphasised the necessity of volunteers for clinical trials, stating, “Without trials we have no progress,” as research into a new antibody for Alzheimer’s disease shows promising results. The ongoing study aims to explore the potential of treating brain inflammation to delay the disease’s progression, prompting calls for further participation in trials.

What remains unclear — It is uncertain how long the trial for the new antibody will take before conclusive results can be evaluated.

London couple participates in pioneering Alzheimer’s treatment trial

London couple participates in pioneering Alzheimer’s treatment trial
Denis with his wife Penny, who has been diagnosed with early onset Alzheimer’s (Picture: UCLH)

When Penny forgot about a lunch date to meet her daughter’s in-laws for the first time, her husband of 45-years knew it was time to go to the doctors.

Denis Horton, 75, was familiar with the signs of memory loss. His friend’s wife had developed dementia just five years earlier, so he was attuned to what could be put down to ageing, and what couldn’t.

Penny, 74, is a ‘voracious reader’ and attentive grandma to her three grandchildren.

She was organised and on top of everyone and everything in her life, having had a long career in the social services before her retirement in 2019.

But in 2019, she started to struggle to remember dates, directions in familiar areas and exciting plans.

She became confused while travelling to a London restaurant to meet her daughter’s partner’s family for the first time

‘That’s when I knew to get her checked out,’ Denis said.

London couple paving way for Alzheimer's cure
Penny decided to take part in the trial at UCLH following her diagnosis (Picture: UCLH)

What followed was plenty of tests, different doctors and trips to clinics across London.

At first, medics at the Acton Memory Clinic were unsure whether Penny had any memory loss problems. But eventually, after blood and cognitive testing, she was diagnosed with early onset Alzheimers.

‘It was difficult to come to terms with,’ Denis said. ‘Especially because we were, and still are, very happy together.’

The couple had met at school in Grimsby, when Denis was 18 and Penny was 16. They had moved to west London, for work and raised four children together.

They are regular theatre-goers, as well as avid walkers, making the reality of their future hard to swallow.

Latest London news

To get the latest news from the capital, visit WTX’s London news hub.

Denis said: ‘Things aren’t as they were, with Penny repeatedly asking a lot of the same questions. But I remind myself to be patient, and aside fromt that we remain a happy couple going about our normal lives.’

London couple paving way for Alzheimer's cure
Penny and Denis with Professor Catherine Mummery who is leading the research (Picture: UCLH)

They immeadiately launched into action finding the best course of treatment to try and delay the disease from developing.

The answer lay in numerous trials, and after researching what would be the best course of action for them, they came across University College Hospital’s pioneering clinical study.

Brain inflammation is a feature of Alzheimer’s progression, and scientists are exploring whether treating this and improving the brain’s natural repair processes helps slow the disease.

This is the first-of-its-kind approach to treatment, and led by Professor Catherine Mummery, they are developing ImmunoBrain’s new antibody.

And results so far are promising. There are no adverse side effects and researchers have observed trends which would indicate improvement.

Professor Mummery said: ‘Without volunteers we have no trials, and without trials we have no progress. At the moment, we are making real progress in the study of Alzheimer’s—and that is down to people like [Penny].

‘There is still a clear need for new treatments that can address the underlying biology of Alzheimer’s disease.

‘These findings suggest that working with the immune system in a different way may offer a promising new direction. While this research is still at an early stage, it is encouraging to see signals that support further study.’

What to Watch

Amazon prime - TV & Netflix

We give you the best picks to binge on this week.

What to Watch

Love Sports

Get your pizza ordered with the latest Live Sports schedule.
Leave A Reply